Brief: Gritstone Bio Highlights The Durability And Potential Broad Utility Of Its Self-Amplifying MRNA Covid-19 Vaccine
30/04/2024 12:12
April 30 (Reuters) - Gritstone bio Inc GRTS.O :
* GRITSTONE BIO HIGHLIGHTS THE DURABILITY AND POTENTIAL
BROAD
UTILITY OF ITS SELF-AMPLIFYING MRNA (SAMRNA) COVID-19 VACCINE AT
ESCMID GLOBAL 2024
Source text for Eikon: ID:nGNX80g7YL
Further company coverage: GRTS.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Gritstone bio
See all newsBrief: Gritstone Bio Inc On Dec 31 2024, Vassiliki “Celia” Economides Became Interim CEO As Well As CFO Of Co
Brief: Gritstone Bio Announces Strengthening Of Maturing Phase 2 PFS Data for GRANITE Study And Provides Business Update
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-Avery Dennison, Snap-On, Avadel Pharma
U.S. STOCKS ON THE MOVE-PPG Industries, Travelers, ShiftPixy